The Department of Defense announced 15 new defense contracts worth a combined $474 million on Wednesday. Among the publicly traded companies winning contracts:
- Pfizer (PFE -2.85%) subsidiary Meridian Medical Technologies won the largest contract of the day, a $123.2 million option exercise (the third one-year-long option out of four possible) to supply U.S. Army, Navy, Air Force, and Marine Corps locations in Maryland and Missouri with nerve agent antidotes in auto-injectors, and to provide these locations with services related to basic maintenance and surge readiness. Delivery is due by Dec. 31, 2014.
- Rockwell Collins (COL) won a $46.6 million sole-source, cost-plus-incentive-fee contract for work on the Air Force's B-2 Common Very Low Frequency Receiver Increment 1 Engineering Manufacturing Development (EMD) Effort. The EMD phase includes the modification, qualification, and testing of the B-2 Common Very Low Frequency Receiver system, and should be completed by June 28, 2018.
- Bell Helicopter Textron (TXT -11.55%) was awarded an $18.6 million foreign military sales contract modification to provide six additional months of contractor logistics support for Bell 407, Huey, Jet Ranger, and OH-58A/C helicopters based in Al Taji, Iraq (formerly Camp Cooke). This contract will now run through Aug. 8, 2014.
- Boeing (BA -1.63%) was awarded a $12.3 million contract modification to continue uninterrupted satellite operations, maintenance, and anomaly resolution for the Space Superiority Systems Directorate's Space Based Space Surveillance Block 10 System through June 20, 2015.
- Oracle (ORCL -1.05%) was awarded a $7 million modification to a U.S. Army contract for Oracle PeopleSoft licenses and maintenance services. This contract remains in force through Dec. 20, 2014.
